The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
9 May 2017
Employment effect (start)
10 May 2017
Foreseen end date
31 December 2018
Description
Polish biotechnology company Selvita has announced that it will create at least 100 jobs at its new research unit in Poznań by the end of 2018. About 50 jobs will be created in the next few months. The company is looking for mainly chemists and biologists. The unit will be on drug discovery projects for the biggest global chemical and pharmaceutical companies.
Selvita was founded in 2007 in Kraków, Poland. Currently, the company employs over 380 scientists. The company has offices in Poland, the USA and the UK.
Sources
9 May 2017: Wirtualny Nowy Przemysł
Citation
Eurofound (2017), Selvita, Business expansion in Poland, factsheet number 90976, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/90976.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
